However, no significant discrepancies in clinical, metabolic, or oxidative stress indicators were observed based on the different genotypes of the ADRB3 rs4994T/C SNP in the control and GDM groups (P > 0.05; Supplementary Table 2). This evidence concerns the gene ADRB3 and gestational diabetes.